These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Sonographic assessment of the severity and progression of autosomal dominant polycystic kidney disease: the Consortium of Renal Imaging Studies in Polycystic Kidney Disease (CRISP). O'Neill WC; Robbin ML; Bae KT; Grantham JJ; Chapman AB; Guay-Woodford LM; Torres VE; King BF; Wetzel LH; Thompson PA; Miller JP Am J Kidney Dis; 2005 Dec; 46(6):1058-64. PubMed ID: 16310571 [TBL] [Abstract][Full Text] [Related]
14. A comparison of ultrasound and magnetic resonance imaging shows that kidney length predicts chronic kidney disease in autosomal dominant polycystic kidney disease. Bhutani H; Smith V; Rahbari-Oskoui F; Mittal A; Grantham JJ; Torres VE; Mrug M; Bae KT; Wu Z; Ge Y; Landslittel D; Gibbs P; O'Neill WC; Chapman AB; Kidney Int; 2015 Jul; 88(1):146-51. PubMed ID: 25830764 [TBL] [Abstract][Full Text] [Related]
15. Correlations between renal function and the total kidney volume measured on imaging for autosomal dominant polycystic kidney disease: A systematic review and meta-analysis. Jo WR; Kim SH; Kim KW; Suh CH; Kim JK; Kim H; Lee JG; Oh WY; Choi SE; Pyo J Eur J Radiol; 2017 Oct; 95():56-65. PubMed ID: 28987699 [TBL] [Abstract][Full Text] [Related]
16. Renal volume in children with ADPKD: size matters. Chapman AB; Guay-Woodford LM Clin J Am Soc Nephrol; 2009 Apr; 4(4):698-9. PubMed ID: 19339418 [No Abstract] [Full Text] [Related]
17. Feasibility of measuring renal blood flow by phase-contrast magnetic resonance imaging in patients with autosomal dominant polycystic kidney disease. Spithoven EM; Meijer E; Borns C; Boertien WE; Gaillard CA; Kappert P; Greuter MJ; van der Jagt E; Vart P; de Jong PE; Gansevoort RT Eur Radiol; 2016 Mar; 26(3):683-92. PubMed ID: 26162576 [TBL] [Abstract][Full Text] [Related]